Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Disease course unaltered by a single intracisternal injection of BMP-7 in ALS mice.

Dreibelbis JE, Brown RH Jr, Pastuszak KA, Smith ER, Kaplan PL, Cudkowicz ME.

Muscle Nerve. 2002 Jan;25(1):122-3. No abstract available.

PMID:
11754197
2.

Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke.

Ren J, Kaplan PL, Charette MF, Speller H, Finklestein SP.

Neuropharmacology. 2000 Mar 3;39(5):860-5.

PMID:
10699451
3.

Microtomographic analysis of healing of femtosecond laser bone calvarial wounds compared to mechanical instruments in mice with and without application of BMP-7.

Girard B, Cloutier M, Wilson DJ, Clokie CM, Miller RJ, Wilson BC.

Lasers Surg Med. 2007 Jun;39(5):458-67.

PMID:
17565733
4.
5.

Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats.

Maric I, Poljak L, Zoricic S, Bobinac D, Bosukonda D, Sampath KT, Vukicevic S.

J Cell Physiol. 2003 Aug;196(2):258-64.

PMID:
12811818
6.

Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein.

Yamamoto M, Takahashi Y, Tabata Y.

Biomaterials. 2003 Nov;24(24):4375-83.

PMID:
12922150
7.

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.

Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R.

Nat Med. 2003 Jul;9(7):964-8.

PMID:
12808448
8.

Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein.

Harvey BK, Hoffer BJ, Wang Y.

Pharmacol Ther. 2005 Feb;105(2):113-25. Epub 2004 Nov 11. Review.

PMID:
15670622
9.

Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation.

Blaney Davidson EN, Vitters EL, van Beuningen HM, van de Loo FA, van den Berg WB, van der Kraan PM.

Arthritis Rheum. 2007 Dec;56(12):4065-73.

11.

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.

Bone. 2006 Feb;38(2):154-66. Epub 2005 Aug 26.

PMID:
16126463
12.

Balance between bone morphogenetic proteins and their antagonists in kidney injury.

Yanagita M.

Ther Apher Dial. 2007 Oct;11 Suppl 1:S38-43.

PMID:
17976084
13.
14.

Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.

Fuchshofer R, Yu AH, Welge-Lüssen U, Tamm ER.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):715-26.

PMID:
17251470
15.

Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice.

Day WA, Koishi K, Nukuda H, McLennan IS.

Neurobiol Dis. 2005 Jun-Jul;19(1-2):323-30.

PMID:
15837588
16.

Effect of bone morphogenetic proteins 2 and 7 on septal chondrocytes in alginate.

Hicks DL, Sage AB, Shelton E, Schumacher BL, Sah RL, Watson D.

Otolaryngol Head Neck Surg. 2007 Mar;136(3):373-9.

PMID:
17321862
17.

Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats.

Chang CF, Morales M, Chou J, Chen HL, Hoffer B, Wang Y.

Neuropharmacology. 2002 Sep;43(3):418-26.

PMID:
12243771
19.

Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold.

Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H.

J Control Release. 2007 Feb 26;117(3):380-6. Epub 2006 Nov 28.

PMID:
17207881

Supplemental Content

Support Center